Why the study?
Does endomyocardial biopsy using the Konno bioptome aid in the differential diagnosis of cardiomyopathies?
Does endomyocardial biopsy using the Konno bioptome aid in the differential diagnosis of cardiomyopathies?
Endomyocardial biopsy using the Konno bioptome is a safe and effective method for the in vivo histological diagnosis of cardiomyopathies, such as endomyocardial fibrosis.
Konno biopsy may aid in-life histological diagnosis in endomyocardial fibrosis; leaves open its role in routine cardiomyopathy evaluation.
The Konno bioptome, adapted to the intracardiac catheter, has been used in 64 patients in the differential diagnosis ofcardiomyopathies, as an additional diagnostic method during standard right heart catheterization and angiocardiography. In the specific instance of endomyocardial fibrosis the Konno biopsy enables histological diagnosis in life. Not surprisingly, in advanced cases dense collagen scar is the usualfeature in endomyocardialfibrosis. The Konno method is a real advance in the evaluation and differential diagnosis of heart disease of obscure origin. The technique of biopsy has proved easy to acquire and it is without hazard. Illustrative data from 5 cases of endomyocardial fibrosis and 2 cases of 'congestive cardiomyopathy' are detailed.
No takes yet. Share an insight, caveat, or question.
Somers et al. (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: